Toggle light / dark theme

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have developed a nanoparticle that can penetrate the blood-brain barrier. Their goal is to kill primary breast cancer tumors and brain metastases in one treatment, and their research shows the method can shrink breast and brain tumors in laboratory studies.

A Birmingham researcher has developed a new high-throughput device that produces libraries of nanomaterials using sustainable mechanochemical approaches.

Dr. Jason Stafford from the University’s School of Engineering invented the platform to create highly controllable reaction conditions and reduce the substantial amount of time researchers spend generating materials in the laboratory.

The benchtop device is a fully automated unit that can be programmed for parallel synthesis to produce a series of novel materials made in subtly different ways, so creating a library of or product formulations for further testing and optimization.

Researchers at AMOLF, working alongside colleagues from Germany, Switzerland, and Austria, have realized a new type of metamaterial through which sound waves flow in an unprecedented fashion. It provides a novel form of amplification of mechanical vibrations, which has the potential to improve sensor technology and information processing devices.

This metamaterial is the first instance of a so-called ‘bosonic Kitaev chain’, which gets its special properties from its nature as a topological material. It was realized by making nanomechanical resonators interact with laser light through radiation pressure forces. The discovery, which is published on March 27 in the renowned scientific journal Nature, was achieved in an international collaboration between AMOLF, the Max Planck Institute for the Science of Light, the University of Basel, ETH Zurich, and the University of Vienna.

The ‘Kitaev chain’ is a theoretical model that describes the physics of electrons in a superconducting material, specifically a nanowire. The model is famous for predicting the existence of special excitations at the ends of such a nanowire: Majorana zero modes. These have gained intense interest because of their possible use in quantum computers.

A Virginia 14-year-old won $25,000 and earned the title of America’s Top Young Scientist this past fall for developing an affordable soap that can treat skin cancer. Heman Bekele plans to refine his invention over the next five years and create a nonprofit to distribute it in low-income communities.

The ninth grader spent four months competing against nine other finalists in 3M and Discovery Education’s Young Scientist Challenge, which encourages kids to “think creatively and apply the power of STEM to discover real-world solutions.” He was paired with a mentor, who helped him turn his idea into a prototype. It works by delivering cancer-fighting agents to the skin by way of lipid nanoparticles.

Bekele told NPR that he’s “always been really passionate about science and how things work,” and his experience growing up in Ethiopia inspired him to develop his soap.

Ohh nice! New vaccine science it seems though I’m not familiar with vaccines, this does seem like a novel approach. It’s kinda future proof to train the immune system to target proteins that are shared across all coronavirus’ I’m hoping it provides, as do they, that it provides a better solution than current vaccines.


The vaccine is made by attaching harmless proteins from different coronaviruses to minuscule nanoparticles that are then injected to prime the body’s defences to fight the viruses should they ever invade.

Because the vaccine trains the immune system to target proteins that are shared across many different types of coronavirus, the protection it induces is extremely broad, making it effective against known and unknown viruses in the same family.

“We’ve shown that a relatively simple vaccine can still provide a scattershot response across a range of different viruses,” said Rory Hills, a graduate researcher at the University of Cambridge and first author of the report. “It takes us one step forward towards our goal of creating vaccines before a pandemic has even started.”